Roche Holding AG (SWX:ROP)

Switzerland · Delayed Price · Currency is CHF

336.00

+0.70 (0.21%)

Jun 26, 2026, 5:30 PM CET

Roche Holding AG Employees

Roche Holding AG had 103,249 employees as of December 31, 2024. The number of employees decreased by 356 or -0.34% compared to the previous year.

Employees

103,249

Change (1Y)

-356

Growth (1Y)

-0.34%

Revenue / Employee

613.62K CHF

Profits / Employee

124.75K CHF

Market Cap

267.97B

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	103,249	-356	-0.34%
Dec 31, 2023	103,605	-8	-0.01%
Dec 31, 2022	103,613	2,693	2.67%
Dec 31, 2021	100,920	-545	-0.54%
Dec 31, 2020	101,465	3,730	3.82%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Related Stocks

Company Name	Employees
Novartis AG	75,267
Galderma Group AG	7,676
Lonza Group AG	20,000
Sandoz Group AG	22,356
Alcon	25,000
Straumann Holding AG	11,821
Sonova Holding AG	18,590
Bachem Holding AG	2,595

Employee Rankings

Roche Holding AG News

20 hours ago - Swiss pharma at risk of US trade investigation, industry body says - Reuters
8 days ago - The U.S. has launched a trade investigation into a German plan to cut spending on pharmaceuticals, a move that could result in fresh tariffs - WSJ
8 days ago - U.S. opens tariff probe targeting Germany's drug pricing policies - CNBC
9 days ago - Genentech says FDA accepts sBLA for for Lunsumio VELO - TheFly
9 days ago - FDA accepts supplemental Biologics License Application for Roche's Lunsumio and Polivy combination for people with relapsed or refractory large B-cell lymphoma - GlobeNewsWire
9 days ago - FDA Accepts Supplemental Biologics License Application for Genentech's Lunsumio and Polivy Combination for People With Relapsed or Refractory Large B-Cell Lymphoma - Business Wire
9 days ago - FDA approves first generic version of Roche's flu drug - Reuters
14 days ago - Drugmakers race to find a place in the next wave of obesity drugs - CNBC